Seroconversion of calves following intravenous injection with embryos exposed to bovine viral diarrhea virus (BVDV) in vitro.
Two recent studies demonstrated that a high-affinity isolate of BVDV (SD-1), remained associated with a small percentage of in vivo-derived bovine embryos following artificial exposure to the virus and either washing or trypsin treatment. Further, the embryo-associated virus was infective in an in vitro environment. Therefore, the objective of this study was to determine if the quantity of a high-affinity isolate of BVDV associated with single-washed or trypsin-treated embryos could cause infection in vivo. Twenty zona-pellucida-intact morulae and blastocysts (MB) were collected on day 7 from superovulated cows. After collection, all MB were washed according to International Embryo Transfer Society (IETS) standards, and all but 4 MB (negative controls) were exposed for 2 h to 10(5)-10(6) cell culture infective doses (50% endpoint) per milliliter (CCID(50)/mL) of viral strain SD-1. Following exposure, according to IETS standards, one half of the MB were washed and one half were trypsin treated. All MB were then individually sonicated, and sonicate fluids were injected intravenously into calves on day 0. Blood was drawn to monitor for viremia and(or) seroconversion. Seroconversion of calves injected with sonicate fluids from washed and trypsin-treated embryos occurred 38% and 13% of the time, respectively. Therefore, the quantity of a high-affinity isolate of BVDV associated with single-washed or trypsin-treated embryos was infective in vivo.
Waldrop
Julie G
JG
College of Veterinary Medicine, Auburn University, 1500 Wire Road, Auburn, AL 36849, USA. waldrja@vetmed.auburn.edu
Stringfellow
David A
DA
Galik
Patricia K
PK
Givens
M Daniel
MD
Riddell
Kay P
KP
Riddell
M Gatz
MG
Carson
Robert L
RL
D000818:Animals; D001755:Blastocyst / Q000821:virology; D002417:Cattle / Q000097:blood* / Q000196:embryology / Q000502:physiology; D030241:Diarrhea Virus 1, Bovine Viral / Q000302:isolation & purification / Q000472:pathogenicity*; D004622:Embryo, Mammalian / Q000821:virology*; D005260:Female; D007275:Injections, Intravenous / Q000662:veterinary; D009028:Morula / Q000821:virology; D011247:Pregnancy; D013010:Sonication; D013480:Superovulation; D020858:Tissue and Organ Harvesting / Q000662:veterinary; D014357:Trypsin / Q000494:pharmacology; D014766:Viremia / Q000097:blood / Q000196:embryology / Q000662:veterinary* / Q000821:virology; D015044:Zona Pellucida / Q000502:physiology
D014357:Trypsin